YWYoshiro Wada

Yoshiro Wada

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yoshiro Wada has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gravity perception disturbance in patients with unilateral Meniere disease

    by Yoshiro Wada, Tomoyuki Shiozaki, Toshiaki Yamanaka, Tadashi Kitahara

    Objective: To investigate gravity perception disturbance (GPD) in patients with Meniere disease (MD), we classified GPD type based on the results of the head‐tilt perception gain (HTPG) and the head‐upright subjective visual vertical (HU‐SVV) evaluated by the head‐tilt SVV (HT‐SVV) test in patients with unilateral MD.Methods: We conducted the HT‐SVV test on 115 patients with unilateral MD and 115 healthy controls. Among the 115 patients, the period from the first vertigo episode to the examination (PFVE) was known for 91 patients.Results: The HT‐SVV test classified 60.9% and 39.1% of patients with unilateral MD as GPD and non‐GPD, respectively. GPD was classified according to HTPG/HU‐SVV combinations as follows: Type A GPD (21.7%, normal HTPG/abnormal HU‐SVV), Type B GPD (23.5%, abnormal HTPG/normal HU‐SVV), and Type C GPD (15.7%, abnormal HTPG/abnormal HU‐SVV). As the PFVE became longer, patients with non‐GPD and Type A GPD decreased; however, those with Types B and C GPD increased.Conclusion: This study provides novel information on unilateral MD from the perspective of gravity perception by classifying GPD based on the results of the HT‐SVV test. This study's findings suggest that overcompensation for vestibular dysfunction in patients with unilateral MD exhibited by large HTPG abnormalities may be strongly associated with persistent postural‐perceptual dizziness.Level of Evidence: 3b

  • Open Access

    Effect of head roll‐tilt on the subjective visual vertical in healthy participants: Towards better clinical measurement of gravity perception

    by Yoshiro Wada, Toshiaki Yamanaka, Tadashi Kitahara, Junichi Kurata

    Objective: Gravity perception is an essential function for spatial orientation and postural stability; however, its assessment is not easy. We evaluated the head‐tilt perception gain (HTPG, that is, mean perceptual gain [perceived/actual tilt angle] during left or right head roll‐tilt conditions) and head‐upright subjective visual vertical (SVV) using a simple method developed by us to investigate the characteristics of gravity perception in healthy participants.Methods: We measured the SVV and head roll‐tilt angle during head roll‐tilt within ±30° of vertical in the sitting and standing positions while the participant maintained an upright trunk (sitting, 434 participants; standing, 263 participants). We evaluated the head‐upright SVV, HTPG, and laterality of the HTPG.Results: We determined the reference ranges of the absolute head‐upright SVV (4.


  • Open Access

    Development of a Clinical Examination to Evaluate Gravity Perception during Static Head Roll Tilt

    by Yoshiro Wada, Toshiaki Yamanaka, Tadashi Kitahara, Junichi Kurata

    日常診療において原因不明の浮動性めまいを訴える患者は多い. われわれは重力感受性障害が浮動性めまいを引き起こすと考え, その仮説を検証する第一段階として重力感受性を定量的に評価する臨床検査法の開発を行った. 予備実験から, 頭部 roll 傾斜角度が30度以内では頭部傾斜角度 (HTA) と頭部傾斜感覚 (HTP) はほぼ直線関係 (相関係数が身体傾斜条件では0.991, 頭部傾斜条件では0.999) となることを示した. この直線性を利用して, 座位における頭部傾斜時の自覚的視性垂直位 (SVV) と HTA から頭部傾斜感覚ゲイン (HTPG) を求める方法を確立し, 頭部傾斜 SVV (HT-SVV) 検査法と名づけた. 重力感受性は HTPG>1であれば過大, HTPG<1であれば過小と評価できる. 健常人329人を対象に HT-SVV 検査を実施し, 解析結果から HTPG (1.02±0.12, 0.80~1.25), HTPG の左右差指数 (4.7±3.7%, 10.0%以下), 頭部直立 SVV の絶対値 (1.1±0.8度, 2.5度以下) の平均値±標準偏差および基準値 (中央値を含む健常人の95%が含まれる範囲) を求めた. 今後, HT-SVV 検査装置のソフト, ハードの簡便化, 迅速化を進め, 浮動性めまいを中心とする各種めまい患者を対象とした臨床データを検討することにより, HT-SVV 検査法の臨床的意義を明らかにしていく予定である.


  • Accuracy assessment of kinect body tracker in instant posturography for balance disorders

    by Hiroyuki Funaya, Tomohiro Shibata, Yoshiro Wada, Toshiaki Yamanaka

    The accuracy of the body-tracking algorithm of Microsoft Kinect SDK was investigated with the aim to apply the device to the medical care of balance disorders. We focused on the inclination of body posture, assuming that Kinect is used for instant posturography in the test of balance. Subjects were asked to participate in several balance tests and the positions of motion-capture markers on subjects were recorded simultaneously with Kinect body-tracking measurements. After calibrating coordinates and compensating for temporal delay between the two sensor systems using a hybrid marker, the correspondence between the body-part locations of Kinect and those of motion capture was modeled by a linear combination model of neighboring markers with optimal parameters, which were estimated according to the criterion of trajectory minimization. The experiment for six healthy adults showed that our method can track body motion at the accuracy required for standard balance tests.


  • Carnitine Deficiency in Inherited Organic Acid Disorders and Reye Syndrome

    by Naruji Sugiyama, Kiyoshi Kidouchi, Masanori Kobayashi, Yoshiro Wada

    A large quantity of propionylcarnitine in the urine of patients with propionic acidemia and methylmalonic aciduria was demonstrated. The amount excreted depended on the administered L-carnitine dose from 25 to 75 mg/kg/day. A high level of propionylcarnitine was also detected in the amniotic fluid of fetuses at risk of methylmalonic aciduria. Glutaric aciduria type 1 was characterized by excessive urinary excretion of glutarylcarnitine. In a neonate with glutaric aciduria type 2, several specific acylcarnitines were detected in the urine. These included isovaleryl-, acetyl-, isobutyryl-, and butyrylcarnitine as major carnitine esters and glutaryl-, and octanoylcarnitine as minor components. However, the pattern of acylcarnitines excreted changed from isovalerylcarnitine (via leucine) to isobutyrylcarnitine (via valine) during early life. In patients diagnosed as Reye syndrome, tissue carnitine deficiency was not always recognized and no decrease in the free/total carnitine ratio was found in the liver or muscle. The clinical and pathophysiological manifestations seen in these disorders are considered to relate to mitochondrial activity. Therefore, it is necessary to measure acylcarnitine fractions in the urine in order to obtain more precise information about mitochondrial function because carnitine and acylcarnitine compounds may express the metabolic state of mitochondria.